LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis

被引:12
作者
Campion, Oceane [1 ,2 ]
Devy, Jessica Thevenard [1 ,2 ]
Billottet, Clotilde [3 ]
Schneider, Christophe [1 ,2 ]
Etique, Nicolas [1 ,2 ]
Dupuy, Jean-William [4 ]
Raymond, Anne-Aurelie [5 ]
Rombi, Camille Boulagnon [2 ,6 ]
Meunier, Marie [1 ,2 ]
Djermoune, El-Hadi [7 ]
Lelievre, Elodie [1 ,2 ]
Wahart, Amandine [1 ,2 ]
Bour, Camille [1 ,2 ]
Hachet, Cathy [1 ,2 ]
Cairo, Stefano [8 ]
Bikfalvi, Andreas [3 ]
Dedieu, Stephane [1 ,2 ]
Devy, Jerome [1 ,2 ]
机构
[1] Univ Reims, UFR Sci Exactes & Nat, F-51687 Reims, France
[2] CNRS, UMR 7369, MEDyC, Matrice Extracellulaire & Dynam Cellulaire, F-51687 Reims, France
[3] Univ Bordeaux, U1029, LAMC, INSERM, F-33600 Pessac, France
[4] Univ Bordeaux, Plateforme Proteome, F-33076 Bordeaux, France
[5] TBM Core US 005, Plateforme Oncoprot, F-33000 Bordeaux, France
[6] CHU Reims, Lab Anat Pathol, F-51100 Reims, France
[7] Univ Lorraine, CRAN, CNRS, F-54000 Nancy, France
[8] Xentech, F-91000 Evry, France
关键词
breast cancer; TNBC; LRP-1; angiogenesis; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; LDL RECEPTOR; PROTEIN-1; METASTASIS; THROMBOSPONDIN-1; EXPRESSION; CHALLENGES; STABILITY; MODULATOR;
D O I
10.3390/biomedicines9101430
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: LRP-1 is a multifunctional scavenger receptor belonging to the LDLR family. Due to its capacity to control pericellular levels of various growth factors and proteases, LRP-1 plays a crucial role in membrane proteome dynamics, which appears decisive for tumor progression. Methods: LRP-1 involvement in a TNBC model was assessed using an RNA interference strategy in MDA-MB-231 cells. In vivo, tumorigenic and angiogenic effects of LRP-1-repressed cells were evaluated using an orthotopic xenograft model and two angiogenic assays (Matrigel(R) plugs, CAM). DCE-MRI, FMT, and IHC were used to complete a tumor longitudinal follow-up and obtain morphological and functional vascular information. In vitro, HUVECs' angiogenic potential was evaluated using a tumor secretome, subjected to a proteomic analysis to highlight LRP-1-dependant signaling pathways. Results: LRP-1 repression in MDA-MB-231 tumors led to a 60% growth delay because of, inter alia, morphological and functional vascular differences, confirmed by angiogenic models. In vitro, the LRP-1-repressed cells secretome restrained HUVECs' angiogenic capabilities. A proteomics analysis revealed that LRP-1 supports tumor growth and angiogenesis by regulating TGF-beta signaling and plasminogen/plasmin system. Conclusions: LRP-1, by its wide spectrum of interactions, emerges as an important matricellular player in the control of cancer-signaling events such as angiogenesis, by supporting tumor vascular morphology and functionality.
引用
收藏
页数:22
相关论文
共 66 条
[1]   Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through upregulation of the plasminogen/plasmin system [J].
Albo, D ;
Berger, DH ;
Wang, TN ;
Hu, XL ;
Rothman, V ;
Tuszynski, GP .
SURGERY, 1997, 122 (02) :493-499
[2]   VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution [J].
Alexander, Revu Ann ;
Prager, Gerald W. ;
Mihaly-Bison, Judit ;
Uhrin, Pavel ;
Sunzenauer, Stefan ;
Binder, Bernd R. ;
Schuetz, Gerhard J. ;
Freissmuth, Michael ;
Breuss, Johannes M. .
CARDIOVASCULAR RESEARCH, 2012, 94 (01) :125-135
[3]   Basal-Like and Triple-Negative Breast Cancers Searching for Positives Among Many Negatives [J].
Alluri, Prasanna ;
Newman, Lisa A. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (03) :567-+
[4]   Effects of Hsp90 Inhibitors on Patient Derived Triple Negative Breast Cancer (TNBC) Cells: BRCA1 as a Therapeutic Target for TNBC [J].
Anant, Shrikant ;
Ramamoorthy, Prabhu ;
Tawfik, Ossama ;
Jensen, Roy A. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) :E6-E6
[5]   Tumor microenvironment complexity and therapeutic implications at a glance [J].
Baghba, Roghayyeh ;
Roshangar, Leila ;
Jahanban-Esfahlan, Rana ;
Seidi, Khaled ;
Ebrahimi-Kalan, Abbas ;
Jaymand, Mehdi ;
Kolahian, Saeed ;
Javaheri, Tahereh ;
Zare, Peyman .
CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
[6]   A gentle approach to investigate the influence of LRP-1 silencing on the migratory behavior of breast cancer cells by atomic force microscopy and dynamic cell studies [J].
Berquand, Alexandre ;
Meunier, Marie ;
Thevenard-Devy, Jessica ;
Ivaldi, Corinne ;
Campion, Oceane ;
Dedieu, Stephane ;
Molinari, Michael ;
Devy, Jerome .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 18 :359-370
[7]   How basal are triple-negative breast cancers? [J].
Bertucci, Francois ;
Finetti, Pascal ;
Cervera, Nathalie ;
Esterni, Benjamin ;
Hermitte, Fabienne ;
Viens, Patrice ;
Birnbaum, Daniel .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (01) :236-240
[8]   Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease [J].
Bianchini, Giampaolo ;
Balko, Justin M. ;
Mayer, Ingrid A. ;
Sanders, Melinda E. ;
Gianni, Luca .
NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (11) :674-690
[9]  
Bikfalvi Andreas, 2009, Journal de la Societe de Biologie, V203, P167, DOI 10.1051/jbio/2009020
[10]  
C Thakur, 2019, J Assoc Physicians India, V67, P70